A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma – (FIGHT-302)
Condition(s):Unresectable Cholangiocarcinoma; Metastatic CholangiocarcinomaLast Updated:October 30, 2020Recruiting